StockData
Mustang Bio, Inc. logo

Mustang Bio, Inc. (MBIO) stock

MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.38−0.01 (-2.56%)

Close on Nov 18, 2026Market cap $2.88MP/E –Yield –

Mustang Bio cash

Cash and short-term investments held at the end of each period.

Mustang Bio's cash was $15.15M at Jun 30, 2026. For fiscal 2025 it was $17.27M, up 152.5% from the year before. The highest annual figure on record is $110.62M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$17.27M+152.5%
FY2024Dec 31, 2024$6.84M-2.1%
FY2023Dec 31, 2023$6.98M-90.9%
FY2022Dec 31, 2022$76.66M-30.7%
FY2021Dec 31, 2021$110.62M+12.0%
FY2020Dec 31, 2020$98.80M+58.3%
FY2019Dec 31, 2019$62.41M+80.5%
FY2018Dec 31, 2018$34.57M-2.5%
FY2017Dec 31, 2017$35.48M+29.0%
FY2016Dec 31, 2016$27.50M–
FY2015Dec 31, 2015$0–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$15.15M+19.7%
Q1 FY2026Mar 31, 2026$16.26M+14.2%
Q4 FY2025Dec 31, 2025$17.27M+152.5%
Q3 FY2025Sep 30, 2025$18.98M+386.8%
Q2 FY2025Jun 30, 2025$12.66M+172.6%
Q1 FY2025Mar 31, 2025$14.23M+731.3%
Q4 FY2024Dec 31, 2024$6.84M-2.1%
Q3 FY2024Sep 30, 2024$3.90M-59.2%
Q2 FY2024Jun 30, 2024$4.64M-69.8%
Q1 FY2024Mar 31, 2024$1.71M-97.1%
Q4 FY2023Dec 31, 2023$6.98M-90.9%
Q3 FY2023Sep 30, 2023$9.56M-89.5%
Q2 FY2023Jun 30, 2023$15.39M-85.7%
Q1 FY2023Mar 31, 2023$58.10M-52.5%
Q4 FY2022Dec 31, 2022$76.66M-30.7%
Q3 FY2022Sep 30, 2022$91.36M-24.4%
Q2 FY2022Jun 30, 2022$107.37M-17.4%
Q1 FY2022Mar 31, 2022$122.22M-5.5%
Q4 FY2021Dec 31, 2021$110.62M+12.0%
Q3 FY2021Sep 30, 2021$120.88M+60.6%
Q2 FY2021Jun 30, 2021$129.92M+52.2%
Q1 FY2021Mar 31, 2021$129.37M+127.7%
Q4 FY2020Dec 31, 2020$98.80M+58.3%
Q3 FY2020Sep 30, 2020$75.25M+2.7%
Q2 FY2020Jun 30, 2020$85.36M+2.7%
Q1 FY2020Mar 31, 2020$56.81M+57.4%
Q4 FY2019Dec 31, 2019$62.41M+80.5%
Q3 FY2019Sep 30, 2019$73.29M+289.9%
Q2 FY2019Jun 30, 2019$83.13M+579.0%
Q1 FY2019Mar 31, 2019$36.10M+97.8%
Q4 FY2018Dec 31, 2018$34.57M-2.5%
Q3 FY2018Sep 30, 2018$18.80M-43.4%
Q2 FY2018Jun 30, 2018$12.24M-77.2%
Q1 FY2018Mar 31, 2018$18.26M-75.7%
Q4 FY2017Dec 31, 2017$35.48M+29.0%
Q3 FY2017Sep 30, 2017$33.21M+198.7%
Q2 FY2017Jun 30, 2017$53.79M–
Q1 FY2017Mar 31, 2017$75.01M–
Q4 FY2016Dec 31, 2016$27.50M–
Q3 FY2016Sep 30, 2016$11.12M–

More Mustang Bio figures

See a number that looks wrong?